BIOCEPT INC Annual Cost of Revenue in USD from 2013 to 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Biocept Inc quarterly/annual Cost of Revenue history and growth rate from 2013 to 2022.
  • Biocept Inc Cost of Revenue for the quarter ending June 30, 2023 was $2.55M, a 68.2% decline year-over-year.
  • Biocept Inc Cost of Revenue for the twelve months ending June 30, 2023 was $15.7M, a 60.5% decline year-over-year.
  • Biocept Inc annual Cost of Revenue for 2022 was $28.4M, a 24.7% decline from 2021.
  • Biocept Inc annual Cost of Revenue for 2021 was $37.8M, a 77% increase from 2020.
  • Biocept Inc annual Cost of Revenue for 2020 was $21.3M, a 94.4% increase from 2019.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $28.4M -$9.32M -24.7% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-17
2021 $37.8M +$16.4M +77% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 $21.3M +$10.4M +94.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-05
2019 $11M +$926K +9.21% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $10.1M +$707K +7.56% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 $9.35M +$2.43M +35% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $6.92M +$2.32M +50.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-28
2015 $4.6M +$2.43M +112% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-28
2014 $2.17M -$159K -6.84% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-10
2013 $2.33M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.